In one study, individual CTLA-4 antibody therapy and CCH ablation decreased the rate of contralateral tumor growth, but there was an even more significant decrease with combined therapy in both melanoma and hepatocellular carcinoma (22). The gene discussed is CTLA4; the disease is melanoma.